Mesothelioma cells have a survival trick. When researchers exposed them to an experimental drug that targeted one of the cancer’s main growth switches, the cells did not die. Instead, they found a way around the drug’s effect. A new study in the journal Nature Structural & Molecular Biology has uncovered[…]
Pleural Mesothelioma
Targeting the Collagen Receptor uPARAP to Treat Mesothelioma
Mesothelioma, a cancer with low survival rates, is still a major problem. A major cause of the cancer is asbestos exposure. A new study focuses on a possible treatment target for mesothelioma. The main focus of researchers in the study is the collagen receptor uPARAP. Mesothelioma is mainly caused by[…]
Diagnosing Mesothelioma
Mesothelioma is a challenging cancer to diagnose, and a recent study highlighted a problem with diagnosing the disease called overdiagnosis. This happens when tumors are mistaken for mesothelioma, leading to big challenges in treatment. The study suggests that doctors need to think beyond just using lab tests for diagnosis. The[…]
Vaccines are Being Studied to Treat Mesothelioma
Vaccines are an important part of preventing infectious diseases from spreading. Vaccines work by utilizing antibody responses and invigorating T-cell immunity. This not only helps with infectious diseases, but it can also help with cancer as well. A new study is looking at a vaccine regimen for mesothelioma. Mesothelioma is[…]
Computers Can Be Used to Help Find Treatments for Mesothelioma
There is some exciting news dealing with the fight against mesothelioma. Scientists are using smart computers to figure out better ways to treat patients. This study is a first step towards making treatments that fit each person better. Mesothelioma is a tricky cancer, and finding the right treatments can be[…]
Using Mesothelin Nanoprobes to Understand Certain Types of Mesothelioma
Mesothelioma is a tough cancer to have that is hard to diagnose and understand. Scientists are looking at a protein called mesothelin that could possibly help. This protein might be a clue to the cancer, but we need an easier way to find out more about it. In the new[…]
Immunotherapy to Treat Pleural Effusion
Malignant pleural effusion is a serious condition where cancer cells spread to the lining of the lungs. This leads to fluid buildup in the chest cavity. This fluid accumulation can make breathing difficult and is often a sign of advanced lung cancer. Pleural effusion is a common symptom of malignant[…]
Tretinoin, a Derivative of Vitamin A, Could Improve the Anti-Cancer Effects of Chemotherapy on Mesothelioma
Tretinoin, a derivative of vitamin A, is showing potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare type of cancer that is hard to diagnose and treat. It develops from the thin layer of tissue that covers[…]
Limited Surgery to Limit Symptoms of Pleural Mesothelioma
A new clinical trial at the University of Chicago is testing whether a smaller, symptom-focused surgery can help pleural mesothelioma patients maintain quality of life when tumor removal is not possible. This study looks at surgery differently compared to other trials. Rather than focusing first on complete tumor removal, it[…]
Radiomics to Determine Mesothelioma
Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Determining which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]
Skip to content